3rd International Biopharmaceutical Industry Development Innovation Forum ...

3rd International Biopharmaceutical Industry Development Innovation Forum has been successfully organized in Shanghai

Promote pharmaceutical research innovation--- advance global innovative drug R&D , create human health

The 3 rd International Biopharmaceutical Industry Development Innovation Forum has been held on Apr. 22 nd -23 rd , 2010 at Renaissance Shanghai PuDong Hotel, which organized by Sino-EU Chemical Manufacturers Association Biomedical Committee (SEBMC)

The Forum focus on a brilliant topic and wide range of issues, More than 200 top leaders and experts from Ministry of Health of the people’s republic of China, Drug Administration Division of China Ministry of Health, STCSM, FRANCE consulate general shanghai, British Consulate general shanghai, Germany Consulate general shanghai, Pfizer, Roche, Novartis, GlaxoSmithKline, MERCK & CO.,INC, Novo Nordisk, AstraZeneca, Eli Lilly, JNJ Pharmaceutical, Servier France, SINOPHARM, FOSUN Pharmaceutical, Northeast Pharmaceutical Group, Harbin pharmaceutical group, WuXi AppTec, People’s Liberation Army Second Military Medical University, JiaoTong University, Fudan University, China Pharmaceutical University, Chinese Academy of Sciences, Shenyang Pharmaceutical University and so on. Two-day meeting biomedical industry concerns global biopharmaceutical R & D innovation and human health ， it was evolved the deeply discussion that in allusion to antibody drug, novel vaccines, genetic engineering drug, anti-infectives, antineoplastic, cardiovascular medicine and so on which resist the effective disease pharmaceutical research, clinical application and asia opportunity, the good environment development of biopharmaceutical industry. It will also explore a unique set of green technology innovation and cooperation mode, and bring solutions to specialty chemical and materials industry. It also explored a unique set of new drug R&D innovation and global innovative pharmaceutical cooperation mode, and pierced into the biopharmaceutical industry innovation all over the world.

During the forum, the international famous pharmaceutical enterprises like Pfizer, Roche, MERCK&CO.,INC, Novartis, AstraZeneca, GlaxoSmithKline, Novo Nordisk, Servier France, these company’s senior leaders participated in performing drug innovation shanghai declaration to spark plug pharmaceutical research innovation, promote global innovative drug development, and also worked together to share with innovative application and future cooperation pharmaceutical research and clinical medicine, which contributed to creating human health.

Exhibition venue, Quite several companies specially set up booths for the innovative biopharmaceutical products exhibitions for public during the conference, such as Thermo Fisher Scientific, MicroConstants Inc, Genomics, Finland BIOHIT, SinoBio Biotech, Siemens, H&J Clinical Research Ltd and so on,

In today’s rapidly changing situation, people keep a very higher aspiration for their life, healthy and value of life, it will be the global pharmaceutical industry development trend under the circumstance of promoting innovative research, creating human health, boosting the development of global innovation biopharmaceutical, SEBMC successfully organized the 3rd International Biopharmaceutical Industry Development Innovation Forum, it also provided a good cooperation platform for global drug R&D and contributed more opportunities to drug innovation and win-win development.

Contact us

tel: +86-21-34241885 34241896
fax: +86-21-64389235
E-mail: secma@
address: 4F ,Offshore Oil Tower, No.583 Lingling Rd, Shanghai, P.R. China Post code ： 200030
URL：
www.